HUHidenori Uda

Hidenori Uda

*This is an algorithmically generated author record based on publicly available information.

Hidenori Uda has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Childhood psychosocial stressors and adult onset arthritis: Broad spectrum risk factors and allostatic load

    by Michael Von Korff, Jordi Alonso, Johan Ormel, Matthais Angermeyer, Ronny Bruffaerts, Clara Fleiz, Giovanni de Girolamo, Ronald C. Kessler, Viviane Kovess-Masfety, José Posada-Villa, et al.

    Neural, endocrine, and immune stress mediators are hypothesized to increase risks of diverse chronic diseases, including arthritis. Retrospective data from the World Mental Health Surveys (N=18,309) were employed to assess whether adult onset of arthritis was associated with childhood adversities and early onset psychological disorder. Cox proportional hazard models assessed the association of number of childhood adversities and the presence of early onset psychological disorder with arthritis age of onset. Controlling for age, sex, and early onset mental disorder, relative to persons with no childhood adversities, persons with two adversities had an increased risk of adult onset arthritis (hazard ratio=1.27, 95% CI=1.08, 1.50), while persons with three or more adversities had a higher risk (HR=1.44, CI=1.24, 1.67). Early onset depressive and/or anxiety disorder was associated with an increased risk of adult onset arthritis after controlling for childhood adversities (HR=1.43, CI=1.28, 1.61). Since psychosocial stressors may be broad spectrum risk factors that increase risks of diverse chronic conditions in later life (e.g. arthritis, heart disease, diabetes, asthma, and chronic pain), prospective studies of childhood psychosocial stressors may be most productive if multiple disease outcomes are assessed in the same study. Results from this study provide methodological guidance for future prospective studies of the relationship between childhood psychosocial stressors and subsequent risk of adult onset arthritis.


  • Childhood Family Adversity Assessment

    by Michael Von Korff, Jordi Alonso, Johan Ormel, Matthais Angermeyer, Ronny Bruffaerts, Clara Fleiz, Giovanni de Girolamo, Ronald C. Kessler, Viviane Kovess-Masfety, José Posada-Villa, et al.

  • Open Access

    A community intervention trial of multimodal suicide prevention program in Japan: A Novel multimodal Community Intervention program to prevent suicide and suicide attempt in Japan, NOCOMIT-J

    by Yutaka Ono, Shuichi Awata, Hideharu Iida, Yasushi Ishida, Naoki Ishizuka, Hiroto Iwasa, Yuichi Kamei, Yutaka Motohashi, Atsuo Nakagawa, Jun Nakamura, et al.

    To respond to the rapid surge in the incidence of suicide in Japan, which appears to be an ongoing trend, the Japanese Multimodal Intervention Trials for Suicide Prevention (J-MISP) have launched a multimodal community-based suicide prevention program, NOCOMIT-J. The primary aim of this study is to examine whether NOCOMIT-J is effective in reducing suicidal behavior in the community. Methods/DesignThis study is a community intervention trial involving seven intervention regions with accompanying control regions, all with populations of statistically sufficient size. The program focuses on building social support networks in the public health system for suicide prevention and mental health promotion, intending to reinforce human relationships in the community. The intervention program components includes a primary prevention measures of awareness campaign for the public and key personnel, secondary prevention measures for screening of, and assisting, high-risk individuals, after-care for individuals bereaved by suicide, and other measures. The intervention started in July 2006, and will continue for 3.5 years. Participants are Japanese and foreign residents living in the intervention and control regions (a total of population of 2,120,000 individuals). The present study is designed to evaluate the effectiveness of the community-based suicide prevention program in the seven participating areas. UMIN Clinical Trials Registry (UMIN-CTR) UMIN000000460.